Abel Sánchez‐Aguilera
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Mesenchymal stem cell research
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Papers in
- Oncology 13
- Cancer-related Molecular Pathways 6
- Cytokine Signaling Pathways and Interactions 3
-
- Epigenetics and DNA Methylation 4
- Co-authors
- Miguel Á. Piris (14 shared papers)Margarita Sánchez‐Beato (7 shared papers)Simón Méndez‐Ferrer (8 shared papers)Daniel Martín-Pérez (4 shared papers)Joan Isern (3 shared papers)Lorena Arranz (4 shared papers)Radek C. Skoda (2 shared papers)Jürg Schwaller (2 shared papers)
- Journals
- Blood (9 papers)Leukemia (2 papers)American Journal Of Pathology (2 papers)Proceedings of the National Academy of Sciences (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- SpainUnited StatesSwitzerland
In The Last Decade
Abel Sánchez‐Aguilera
31 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 97
- Genetics 564
- Hematology 564
- Pathology and Forensic Medicine 508
- Oncology 646
- Immunology 485
Countries citing papers authored by Abel Sánchez‐Aguilera
This map shows the geographic impact of Abel Sánchez‐Aguilera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abel Sánchez‐Aguilera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abel Sánchez‐Aguilera more than expected).
Fields of papers citing papers by Abel Sánchez‐Aguilera
This network shows the impact of papers produced by Abel Sánchez‐Aguilera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abel Sánchez‐Aguilera. The network helps show where Abel Sánchez‐Aguilera may publish in the future.
Co-authors
The 25 scholars most cited alongside Abel Sánchez‐Aguilera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 324 | |
| 2 | 2003 | 286 | |
| 3 | 2007 | 252 | |
| 4 | 2008 | 176 | |
| 5 | 2013 | 114 | |
| 6 | 2005 | 111 | |
| 7 | 2005 | 106 | |
| 8 | 2006 | 105 | |
| 9 | 2014 | 91 | |
| 10 | 2016 | 70 | |
| 11 | 2001 | 68 | |
| 12 | 2015 | 59 | |
| 13 | 2007 | 54 | |
| 14 | 2003 | 51 | |
| 15 | 2002 | 46 | |
| 16 | 2009 | 42 | |
| 17 | 2003 | 40 | |
| 18 | 2012 | 35 | |
| 19 | 2008 | 33 | |
| 20 | 2011 | 28 |
About Abel Sánchez‐Aguilera
Abel Sánchez‐Aguilera is a scholar working on Oncology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Hematology, having authored 31 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer-related Molecular Pathways (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (4 papers), Epigenetics and DNA Methylation (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (564 citations), Hematology (564 citations), Pathology and Forensic Medicine (508 citations), Oncology (646 citations) and Immunology (485 citations). Abel Sánchez‐Aguilera has collaborated with scholars based in Spain, United States and Switzerland. Frequent co-authors include Miguel Á. Piris, Margarita Sánchez‐Beato, Simón Méndez‐Ferrer, Daniel Martín-Pérez, Joan Isern, Lorena Arranz, Radek C. Skoda, Jürg Schwaller, Marina Pollán and Xavier Langa. Their work appears in journals such as Blood, Leukemia, American Journal Of Pathology, Proceedings of the National Academy of Sciences and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.